These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24611071)

  • 1. Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia?
    Alsolami R; Knight SJ; Schuh A
    Per Med; 2013 Jun; 10(4):361-376. PubMed ID: 24611071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
    Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
    Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Ryder CB; Oduro KA; Moore EM
    Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologies.
    Gunnarsson R; Mansouri L; Rosenquist R
    Leuk Lymphoma; 2013 Aug; 54(8):1583-90. PubMed ID: 23167608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.
    Perini GF; Feres CCP; Teixeira LLC; Hamerschlak N
    Curr Treat Options Oncol; 2021 Jun; 22(8):66. PubMed ID: 34110507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic features of B-cell chronic lymphocytic leukemia.
    Stilgenbauer S; Lichter P; Döhner H
    Rev Clin Exp Hematol; 2000 Mar; 4(1):48-72. PubMed ID: 11486330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of genetic defects in chronic lymphocytic leukemia.
    Rossi D; Fangazio M; Gaidano G
    Mediterr J Hematol Infect Dis; 2012; 4(1):e2012076. PubMed ID: 23205264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving understanding of the CLL genome.
    Gruber M; Wu CJ
    Semin Hematol; 2014 Jul; 51(3):177-87. PubMed ID: 25048782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on the Application of Cytogenomic Approaches in Chronic Lymphocytic Leukaemia.
    Wan Mohamad Zamri WN; Mohd Yunus N; Abdul Aziz AA; Zulkipli NN; Sulong S
    Diagnostics (Basel); 2023 Mar; 13(5):. PubMed ID: 36900108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.
    Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG
    Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
    Hallek M
    Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia.
    Zhang L; Znoyko I; Costa LJ; Conlin LK; Daber RD; Self SE; Wolff DJ
    Cancer Genet; 2011 Dec; 204(12):654-65. PubMed ID: 22285017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The genetic landscape of chronic lymphocytic leukemia].
    Marosvári D; Alpár D; Király AP; Rajnai H; Reiniger L; Bödör C
    Magy Onkol; 2016 Jun; 60(2):118-25. PubMed ID: 27275638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics, gene expression, and targeted therapies in chronic lymphocytic leukemia.
    Winkler D; Döhner H; Stilgenbauer S
    Curr Drug Targets; 2006 Oct; 7(10):1313-27. PubMed ID: 17073593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological relevance of genomic heterogeneity in chronic lymphocytic leukemia.
    Friedman DR; Lucas JE; Weinberg JB
    PLoS One; 2013; 8(2):e57356. PubMed ID: 23468975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation (6;13)(p21;q14.1) as a rare nonrandom cytogenetic abnormality in chronic lymphocytic leukemia.
    Karakosta M; Voulgarelis M; Vlachadami I; Manola KN
    Cancer Genet Cytogenet; 2010 Apr; 198(1):66-70. PubMed ID: 20303017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biomarkers in chronic lymphocytic leukemia.
    Malek S
    Adv Exp Med Biol; 2013; 792():193-214. PubMed ID: 24014298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of comparative genomic hybridization and fluorescence in situ hybridization to the detection of chromosomal abnormalities in B-cell chronic lymphocytic leukemia.
    Jarosová M; Jedlicková K; Holzerová M; Urbanová R; Papajík T; Raida L; Pikalová Z; Lakomá I; Prekopová I; Kropácková J; Indrák K
    Onkologie; 2001 Feb; 24(1):60-5. PubMed ID: 11441283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia.
    Malek SN
    Oncogene; 2013 Jun; 32(23):2805-17. PubMed ID: 23001040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.